相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。X Chromosome inactivation: a modifier of factor VIII and IX plasma levels and bleeding phenotype in Haemophilia carriers
Isabella Garagiola et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2021)
Globotriaosylsphingosine (lyso-Gb3) and analogues in plasma and urine of patients with Fabry disease and correlations with long-term treatment and genotypes in a nationwide female Danish cohort
Grigoris Effraimidis et al.
JOURNAL OF MEDICAL GENETICS (2021)
X-chromosome inactivation patterns in females with Fabry disease examined by both ultra-deep RNA sequencing and methylation-dependent assay
Rini Rossanti et al.
CLINICAL AND EXPERIMENTAL NEPHROLOGY (2021)
Pharmacological Chaperones: A Therapeutic Approach for Diseases Caused by Destabilizing Missense Mutations
Ludovica Liguori et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Developments in the treatment of Fabry disease
Sanne J. van der Veen et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2020)
Treatment of Anderson-Fabry Disease
Irene Simonetta et al.
CURRENT PHARMACEUTICAL DESIGN (2020)
The role of Immunity in Fabry Disease and Hypertension: A Review of a Novel Common Pathway
Rita Del Pinto et al.
HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION (2020)
X-Chromosome Inactivation Is a Biomarker of Clinical Severity in Female Carriers of RPGR-Associated X-Linked Retinitis Pigmentosa
Abigail T. Fahim et al.
OPHTHALMOLOGY RETINA (2020)
Current and Investigational Therapeutics for Fabry Disease
Andrew Felis et al.
KIDNEY INTERNATIONAL REPORTS (2020)
Identification of lysosomal and extralysosomal globotriaosylceramide (Gb3) accumulations before the occurrence of typical pathological changes in the endomyocardial biopsies of Fabry disease patients
Ming-Jia Hsu et al.
GENETICS IN MEDICINE (2019)
High incidence of co-existing factors significantly modifying the phenotype in patients with Fabry disease
Serhat Koca et al.
GENE (2019)
Interfamily variability in patients with classical Fabry disease
Dawn A. Laney
MOLECULAR GENETICS AND METABOLISM (2019)
X-Linked Emery-Dreifuss Muscular Dystrophy: Study Of X-Chromosome Inactivation and Its Relation with Clinical Phenotypes in Female Carriers
Emanuela Viggiano et al.
GENES (2019)
Hypertrophic cardiomyopathy: genetics and clinical perspectives
Cordula Maria Wolf
CARDIOVASCULAR DIAGNOSIS AND THERAPY (2019)
Semen and male genital tract characteristics of patients with Fabry disease: the FERTIFABRY multicentre observational study
Aline Papaxanthos-Roche et al.
BASIC AND CLINICAL ANDROLOGY (2019)
Ventricular arrhythmia and sudden cardiac death in Fabry disease: a systematic review of risk factors in clinical practice
Shanat Baig et al.
EUROPACE (2018)
Investigation of correlation of urinary globotriaosylceramide (Gb3) levels with markers of renal function in patients with Fabry disease
Alana Pimentel Moura et al.
CLINICA CHIMICA ACTA (2018)
Agalsidase alfa versus agalsidase beta for the treatment of Fabry disease: an international cohort study
Maarten Arends et al.
JOURNAL OF MEDICAL GENETICS (2018)
Fabry disease revisited: Management and treatment recommendations for adult patients
Alberto Ortiz et al.
MOLECULAR GENETICS AND METABOLISM (2018)
Galactose-1-phosphate uridyltransferase deficiency: A literature review of the putative mechanisms of short and long-term complications and allelic variants
E. Viggiano et al.
CLINICAL GENETICS (2018)
Reassessment of Mendelian gene pathogenicity using 7,855 cardiomyopathy cases and 60,706 reference samples
Roddy Walsh et al.
GENETICS IN MEDICINE (2017)
Oral pharmacological chaperone migalastat compared with enzyme replacement therapy in Fabry disease: 18-month results from the randomised phase III ATTRACT study
Derralynn A. Hughes et al.
JOURNAL OF MEDICAL GENETICS (2017)
Skewed X-chromosome inactivation plays a crucial role in the onset of symptoms in carriers of Becker muscular dystrophy
Emanuela Viggiano et al.
JOURNAL OF GENE MEDICINE (2017)
Favourable effect of early versus late start of enzyme replacement therapy on plasma globotriaosylsphingosine levels in men with classical Fabry disease
Maarten Arends et al.
MOLECULAR GENETICS AND METABOLISM (2017)
Inter-familial and intra-familial phenotypic variability in three Sicilian families with Anderson-Fabry disease
Antonino Tuttolomondo et al.
ONCOTARGET (2017)
Different renal phenotypes in related adult males with Fabry disease with the same classic genotype
Renzo Mignani et al.
MOLECULAR GENETICS & GENOMIC MEDICINE (2017)
Retrospective study of long-term outcomes of enzyme replacement therapy in Fabry disease: Analysis of prognostic factors
Maarten Arends et al.
PLOS ONE (2017)
X-chromosome inactivation in female patients with Fabry disease
L. Echevarria et al.
CLINICAL GENETICS (2016)
Determining the role of skewed X-chromosome inactivation in developing muscle symptoms in carriers of Duchenne muscular dystrophy
Emanuela Viggiano et al.
HUMAN GENETICS (2016)
Treatment of Fabry's Disease with the Pharmacologic Chaperone Migalastat
D. P. Germain et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Genotype: A Crucial but Not Unique Factor Affecting the Clinical Phenotypes in Fabry Disease
Xiaoxia Pan et al.
PLOS ONE (2016)
Understanding the gastrointestinal manifestations of Fabry disease: promoting prompt diagnosis
Claire Zar-Kessler et al.
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2016)
Enzyme replacement therapy for Anderson-Fabry disease
Regina El Dib et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2016)
The Large Phenotypic Spectrum of Fabry Disease Requires Graduated Diagnosis and Personalized Therapy: A Meta-Analysis Can Help to Differentiate Missense Mutations
Valentina Citro et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Fabry disease and the heart
Nora Seydelmann et al.
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2015)
Genetic advances in sarcomeric cardiomyopathies: state of the art
Carolyn Y. Ho et al.
CARDIOVASCULAR RESEARCH (2015)
Pathology and Function of Conduction Tissue in Fabry Disease Cardiomyopathy
Andrea Frustaci et al.
CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY (2015)
Results of clinical genetic testing of 2,912 probands with hypertrophic cardiomyopathy: expanded panels offer limited additional sensitivity
Ahmed A. Alfares et al.
GENETICS IN MEDICINE (2015)
Elevated Endomyocardial Biopsy Macrophage-Related Markers in Intractable Myocardial Diseases
Yuka Hayashi et al.
INFLAMMATION (2015)
Plasma globotriaosylsphingosine in relation to phenotypes of Fabry disease
Bouwien E. Smid et al.
JOURNAL OF MEDICAL GENETICS (2015)
Fabry disease in infancy and early childhood: a systematic literature review
Dawn A. Laney et al.
GENETICS IN MEDICINE (2015)
Establishing 3-nitrotyrosine as a biomarker for the vasculopathy of Fabry disease
Liming Shu et al.
KIDNEY INTERNATIONAL (2014)
X-linked glycogen storage disease IXa manifested in a female carrier due to skewed X chromosome inactivation
Sun Young Cho et al.
CLINICA CHIMICA ACTA (2013)
Comparison of X-chromosome inactivation in Duchenne muscle/myocardium-manifesting carriers, non-manifesting carriers and related daughters
E. Viggiano et al.
CLINICAL GENETICS (2013)
Two-dimensional speckle tracking as a non-invasive tool for identification of myocardial fibrosis in Fabry disease
Johannes Kraemer et al.
EUROPEAN HEART JOURNAL (2013)
Inherited Cardiomyopathies Molecular Genetics and Clinical Genetic Testing in the Postgenomic Era
Polakit Teekakirikul et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2013)
Fabry disease peripheral blood immune cells release inflammatory cytokines: Role of globotriaosylceramide
Pablo N. De Francesco et al.
MOLECULAR GENETICS AND METABOLISM (2013)
Fibrosis: a key feature of Fabry disease with potential therapeutic implications
Frank Weidemann et al.
ORPHANET JOURNAL OF RARE DISEASES (2013)
Fabry_CEP: a tool to identify Fabry mutations responsive to pharmacological chaperones
Marco Cammisa et al.
ORPHANET JOURNAL OF RARE DISEASES (2013)
Functional Characterisation of Alpha-Galactosidase A Mutations as a Basis for a New Classification System in Fabry Disease
Jan Lukas et al.
PLOS GENETICS (2013)
Globotriaosylceramide is correlated with oxidative stress and inflammation in Fabry patients treated with enzyme replacement therapy
Giovana B. Biancini et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2012)
Vascular Aspects of Fabry Disease in Relation to Clinical Manifestations and Elevations in Plasma Globotriaosylsphingosine
Saskia M. Rombach et al.
HYPERTENSION (2012)
Synergy between the pharmacological chaperone 1-deoxygalactonojirimycin and the human recombinant alpha-galactosidase A in cultured fibroblasts from patients with Fabry disease
Caterina Porto et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2012)
2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
Bernard J. Gersh et al.
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY (2011)
Symptomatic dystrophinopathies in female children
Natashia Seemann et al.
NEUROMUSCULAR DISORDERS (2011)
Differences in Fabry Cardiomyopathy Between Female and Male Patients Consequences for Diagnostic Assessment
Markus Niemann et al.
JACC-CARDIOVASCULAR IMAGING (2011)
Plasma globotriaosylsphingosine: Diagnostic value and relation to clinical manifestations of Fabry disease
S. M. Rombach et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2010)
Vasculopathy in patients with Fabry disease: Current controversies and research directions
S. M. Rombach et al.
MOLECULAR GENETICS AND METABOLISM (2010)
Plasma globotriaosylsphingosine as a biomarker of Fabry disease
Tadayasu Togawa et al.
MOLECULAR GENETICS AND METABOLISM (2010)
Clinical and genetic characterization of manifesting carriers of DMD mutations
Payam Soltanzadeh et al.
NEUROMUSCULAR DISORDERS (2010)
Expression of the disease on female carriers of X-linked lysosomal disorders: a brief review
Louise L. C. Pinto et al.
ORPHANET JOURNAL OF RARE DISEASES (2010)
X-linked inheritance and its implication in the diagnosis and management of female patients in Fabry disease
D. P. Germain et al.
REVUE DE MEDECINE INTERNE (2010)
Homozygous Female Becker Muscular Dystrophy
Katsunori Fujii et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2009)
Long-Term Effects of Enzyme Replacement Therapy on Fabry Cardiomyopathy Evidence for a Better Outcome With Early Treatment
Frank Weidemann et al.
CIRCULATION (2009)
Fabry disease in children and the effects of enzyme replacement treatment
Guillem Pintos-Morell et al.
EUROPEAN JOURNAL OF PEDIATRICS (2009)
X chromosome inactivation in clinical practice
Karen Helene Orstavik
HUMAN GENETICS (2009)
HEART VALVE INVOLVEMENT IN FABRY CARDIOMYOPATHY
Frank Weidemann et al.
ULTRASOUND IN MEDICINE AND BIOLOGY (2009)
Skewed X chromosome inactivation in fraternal female twins results in moderately severe and mild haemophilia B
K. Okumura et al.
HAEMOPHILIA (2008)
No evidence that skewing of X chromosome inactivation patterns is transmitted to offspring in humans
Veronique Bolduc et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Disease Rarity, Carrier Status, and Gender: A Triple Disadvantage for Women with Fabry Disease
Andrea L. Gibas et al.
Journal of Genetic Counseling (2008)
X Inactivation, Female Mosaicism, and Sex Differences in Renal Diseases
Barbara R. Migeon
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
Females with Fabry disease frequently have major organ involvement: Lessons from the Fabry Registry
William R. Wilcox et al.
MOLECULAR GENETICS AND METABOLISM (2008)
Globotriaosylceramide induces oxidative stress and up-regulates cell adhesion molecule expression in Fabry disease endothelial cells
Jin-Song Shen et al.
MOLECULAR GENETICS AND METABOLISM (2008)
Elevated globotriaosylsphingosine is a hallmark of Fabry disease
Johannes M. Aerts et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Nomen est Omen
F. Weidemann et al.
EUROPEAN JOURNAL OF ECHOCARDIOGRAPHY (2008)
Three-dimensional face shape in Fabry disease
Josanne Cox-Brinkman et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2007)
The Dutch Fabry cohort:: Diversity of clinical manifestations and Gb3 levels
A. C. Vedder et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2007)
Heterozygous Fabry women are not just carriers, but have a significant burden of disease and impaired quality of life
Raymond Y. Wang et al.
GENETICS IN MEDICINE (2007)
Increased skewing of X chromosome inactivation with age in both blood and buccal cells
G. P. S. Knudsen et al.
CYTOGENETIC AND GENOME RESEARCH (2007)
X chromosome-inactivation patterns of 1,005 phenotypically unaffected females
James M. Amos-Landgraf et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2006)
High incidence of later-onset Fabry disease revealed by newborn screening
Marco Spada et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2006)
Disease manifestations and X inactivation in heterozygous females with Fabry disease
Esther M. Maier et al.
ACTA PAEDIATRICA (2006)
The role of X inactivation and cellular mosaicism in women's health and sex-specific diseases
BR Migeon
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Quantitative dysmorphology assessment in Fabry disease
M Ries et al.
GENETICS IN MEDICINE (2006)
Relationship between X-inactivation and clinical involvement in Fabry heterozygotes.: Eleven novel mutations in the α-galactosidase A gene in the Czech and Slovak population
R Dobrovolny et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2005)
Familial cases of point mutations in the XIST promoter reveal a correlation between CTCF binding and pre-emptive choices of X chromosome inactivation
EM Pugacheva et al.
HUMAN MOLECULAR GENETICS (2005)
The molecular defect leading to Fabry disease:: Structure of human α-galactosidase
SC Garman et al.
JOURNAL OF MOLECULAR BIOLOGY (2004)
Prenatal diagnosis of DMD in a female foetus affected by Turner syndrome
V Satre et al.
PRENATAL DIAGNOSIS (2004)
Fabry disease: Detection of undiagnosed hemodialysis patients and identification of a renal variant phenotype
S Nakao et al.
KIDNEY INTERNATIONAL (2003)
Fabry disease: molecular studies in Italian patients and X inactivation analysis in manifesting carriers
A Morrone et al.
JOURNAL OF MEDICAL GENETICS (2003)
X-inactivation patterns in carriers of X-linked myotubular myopathy
M Kristiansen et al.
NEUROMUSCULAR DISORDERS (2003)
Early detection of Fabry cardiomyopathy by tissue Doppler imaging
M Pieroni et al.
CIRCULATION (2003)
Fabry disease, an under-recognized multisystemic disorder: Expert recommendations for diagnosis, management, and enzyme replacement therapy
RJ Desnick et al.
ANNALS OF INTERNAL MEDICINE (2003)
Gadolinium enhanced cardiovascular magnetic resonance in Anderson-Fabry disease - Evidence for a disease specific abnormality of the myocardial interstitium
JCC Moon et al.
EUROPEAN HEART JOURNAL (2003)
Fabry disease in patients with hypertrophic cardiomyopathy (HCM)
G Beer et al.
ZEITSCHRIFT FUR KARDIOLOGIE (2002)
Cardiac manifestations of Anderson-Fabry disease in heterozygous females
C Kampmann et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2002)
Anderson-Fabry disease:: Clinical manifestations of disease in female heterozygotes
C Whybra et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2001)
Anderson-Fabry disease: clinical manifestations and impact of disease in a cohort of 60 obligate carrier females
KD MacDermot et al.
JOURNAL OF MEDICAL GENETICS (2001)
A novel X chromosome-linked genetic cause of recurrent spontaneous abortion
MC Lanasa et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2001)
Enzyme replacement therapy in Fabry disease - A randomized controlled trial
R Schiffmann et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Pain in Anderson-Fabry's disease
MMU Chowdhury et al.
LANCET (2001)
Cardiac manifestations in Fabry disease
A Linhart et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2001)
Clinical features of and recent advances in therapy for Fabry disease
RO Brady et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
Age- and tissue-specific variation of X chromosome inactivation ratios in normal women
A Sharp et al.
HUMAN GENETICS (2000)
分享论文
